United Therapeutics to Complete $2 Billion Buyback With $477.6M ASR
United Therapeutics Corporation (Nasdaq: UTHR) will repurchase approximately $477.6 million of its common stock through an accelerated share repurchase agreement... Read More
The post United Therapeutics to Complete $2 Billion Buyback With $477.6M ASR appeared first on citybiz.